Clinics in Laboratory Medicine

Papers
(The TQCC of Clinics in Laboratory Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Strategic Leadership in Laboratory Medicine: Navigating Belonging, Resilience, and Organizational Culture26
Forthcoming Issues17
Advances in Hemostasis Laboratory Testing16
Current Topics in Molecular Diagnostics and Precision Medicine15
Promoting Health Equity Through Effective Laboratory Stewardship Strategies15
Molecular Detection of Oncogenic Gene Rearrangements13
Contributors12
Digital Imaging and AI Pre-classification in Hematology11
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists11
Molecular Pathology of Ovarian Epithelial Neoplasms11
Leadership's Role in Paving the Path to Diversity, Equity, and Inclusion in Laboratory Medicine10
Point-of-Care Drug Testing10
Copy Number Analysis in Cancer Diagnostic Testing10
Molecular Oncology Diagnostics10
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory10
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation9
Is It Possible to Test for Viral Infectiousness?9
Contributors8
Contributors8
Contributors8
Cell-free Nucleic Acids in Cancer8
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities8
Opportunities and Challenges with Artificial Intelligence in Genomics8
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders8
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing7
Contents7
Leadership Approaches for Work-Life Balance, Well-Being, and Diversity, Equity, and Inclusion Support in the Laboratory7
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests7
Contextualizing Race and Ethnicity in the Practice of Laboratory Medicine7
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP537
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology6
Contents6
Flow Cytometry and Platelets6
Artificial Intelligence for Clinical Flow Cytometry6
Copyright6
Morphologic Characteristics of Myelodysplastic Syndromes5
The Evolving Role of Molecular Diagnostics in Pathology5
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe5
Transfusion Medicine: Renovation, Innovation, and Evolution5
Molecular Alterations in Pediatric Solid Tumors5
Expanding the Blood Donor Pool5
The Impact of Inclusive Excellence Initiatives on Laboratory Wellness5
Implementation of Viscoelastic Testing at the Point of Care5
The Role of Artificial Intelligence in Transfusion Medicine5
Electronic Health Record Optimization for Artificial Intelligence5
Steps Forward to a Fair and Inclusive Blood Supply5
Updates on Von Willebrand Disease Testing5
Copyright5
Molecular Diagnostics for Invasive Molds: From Lab to Bedside5
Molecular Biomarkers of Response to Cancer Immunotherapy5
Taking Center Stage4
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)4
Utility of Single-Gene Testing in Cancer Specimens4
Platelet Laboratory Testing: Integration of Molecular Testing and Advanced Methods4
Point of Care Molecular Testing4
von Willebrand Disease and von Willebrand Factor4
Review of Established and Emerging Infectious Diseases in Transfusion Medicine4
Artificial Intelligence in the Clinical Laboratory4
Updates in Antiphospholipid Syndrome Laboratory Diagnosis4
Rapid Antigen Assays for SARS-CoV-24
The Mass Spectrometry Revolution in Clinical Microbiology Part 24
Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome4
Viscoelastic Testing for the Laboratorian3
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults3
Contents3
Contents3
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms3
Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels3
Analytical Principles of Cancer Next Generation Sequencing3
Copyright3
Update on Ovarian Sex Cord–Stromal Tumors3
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-23
Copyright3
Molecular Methods3
Bacterial Risk Mitigation Strategies for Platelets3
Pathology Clinics Can Address Pathology Burnout3
A Winding Road to Health Care Equity in Sickle Cell Disease3
Diagnostic Stewardship for Multiplex Respiratory Testing3
Contributors3
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility3
Copyright3
An Overview of Common Donor and Therapeutic Apheresis Procedures3
Molecular Pathology of Breast Tumors3
Childhood Myelodysplastic Syndrome3
0.51273894309998